Impact of hepatitis C status on 20-year mortality of patients with substance use disorders

Table 2 Mortality at 20 years, by subgroup

Demographic	Alive	Deceased	% deceased, %	P
Totals	362	82	18
Age mean, years	32.8	37.9		<0.0001
Gender
M	222	66	23
F	140	16	10	0.001
Race*
White	83	35	30
Black	278	47	14	0.001
Hx IDU
Yes	244	57	19
No	118	25	17	0.72
Drugs of abuse
Alcohol
Yes	237	63	21
No	125	19	13	0.05
Cocaine
Yes	263	52	17
No	99	30	23	0.1
Heroin
Yes	233	51	18
No	129	31	19	0.71
Methadone
Yes	27	12	31
No	335	70	17	0.04
Benzodiazepines
Yes	61	19	24
No	301	63	17	0.18
Marijuana
Yes	90	20	18
No	272	62	19	0.93
Hx STD
Yes	152	23	13
No	210	59	22	0.02
Hep C Ab
Positive	228	56	20
Negative	134	26	16	0.37
Hep BSAg
Positive	10	4	29
Negative	352	78	18	0.32
HepBSab
Positive	115	27	19
Negative	247	55	18	0.84
HIV
Positive	23	7	23
Negative*	339	74	18	0.46
RPR
Positive	23	29	56
Negative	339	415	55	0.75
AST
<31	210	39	16
>31 and <60	86	23	21	0.21
>60	66	20	23
ALT
<31	193	39	17
>31 and <60	91	23	20	0.64
>60	78	20	20

ISSN: 1940-0640